Tower Research Capital LLC (Trc) Stoke Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,930 shares of STOK stock, worth $102,598. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,930
Previous 7,012
70.14%
Holding current value
$102,598
Previous $86,000
52.33%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding STOK
# of Institutions
136Shares Held
57.3MCall Options Held
5.7KPut Options Held
24.4K-
Skorpios Trust6.91MShares$59.4 Million99.8% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$46.5 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$44.6 Million22.22% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$44.1 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$39.9 Million0.57% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $339M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...